What it’s worthwhile to know:

– Kahun, a pioneer in medical data structuring, has launched a brand new AI agent particularly designed for the pharmaceutical business.

– The AI ​​Agent goals to bridge the hole between medical data and the affected person context and supply professionals with dependable and accessible details about medicines.

Addressing the Challenges of Pharmaceutical Data

The speedy tempo of drug improvement and analysis has made it more and more tough for healthcare professionals to remain abreast of the most recent developments. Kahun’s AI Agent addresses this problem by structuring medical data in a approach that’s simply accessible and comprehensible.

Advantages for pharmaceutical corporations

Utilizing Kahun's AI Agent, pharmaceutical corporations can:

• Enhance affected person administration: Acquire perception into affected person wants and establish potential remedy choices.
• Scale back the variety of drug deliveries: Empower professionals with the data they should optimize affected person outcomes.
• Promote product consciousness: Improve consciousness of present and new pharmaceutical merchandise.

“The launch of a pharma-focused AI Agent is one other necessary milestone for our group to enhance sufferers’ lives by offering healthcare professionals with instruments that make a optimistic distinction of their workflows,” mentioned Dr. Michal Tzuchman Katz, CEO and co-founder of Kahun. “New medical data is changing into out there at a speedy and thrilling tempo, nevertheless it provides an amazing quantity of knowledge for healthcare professionals to navigate. With workloads already impacting the doctor-patient interplay, our device is constructed to make data simply accessible.”